What is the appropriate tapering schedule for sertraline and subsequent initiation of bupropion in a patient with postural orthostatic tachycardia syndrome who is currently taking 35 mg sertraline?

Sertraline Tapering and Bupropion Initiation in POTS

For a patient with POTS currently on 35 mg sertraline, taper the sertraline gradually over several weeks using small dose reductions (e.g., reduce by 10 mg every 2-4 weeks down to very low doses like 5-10 mg before stopping), then initiate bupropion at 150 mg once daily after completing the taper, monitoring closely for both withdrawal symptoms and POTS symptom changes.

Rationale for Sertraline Tapering Approach

The 35 mg dose is already below the typical therapeutic minimum (50 mg), but this doesn't eliminate withdrawal risk. Recent evidence demonstrates that tapering should be hyperbolic rather than linear, with smaller reductions as you approach lower doses 1. The traditional guideline recommendation of 25-50% reductions over 2-6 weeks applies primarily to therapeutic doses 2, but your patient is already at a sub-therapeutic level.

Specific Tapering Schedule for 35 mg Sertraline:

• Week 0-2: 35 mg daily
• Week 2-4: 25 mg daily (reduce by 10 mg)
• Week 4-6: 15 mg daily (reduce by 10 mg)
• Week 6-8: 10 mg daily (reduce by 5 mg)
• Week 8-10: 5 mg daily (reduce by 5 mg)
• Week 10+: Discontinue

This gradual approach minimizes withdrawal symptoms, which can include dizziness, anxiety, and autonomic instability—all particularly problematic in POTS patients 2, 1.

Critical Pitfall to Avoid:

Never use alternate-day dosing when tapering sertraline. Despite being commonly recommended in practice, recent pharmacokinetic modeling shows this approach causes dramatic fluctuations in serotonin transporter occupancy, significantly increasing withdrawal symptom risk 3. The inter-dose interval variation creates a "roller coaster" effect that can be particularly destabilizing for POTS patients whose autonomic systems are already dysregulated.

Bupropion Initiation After Sertraline Taper

Once sertraline is fully discontinued and the patient has been off for at least 1-2 weeks to ensure clearance and assess baseline POTS symptoms, initiate bupropion.

Bupropion Dosing in POTS Context:

Start with 150 mg extended-release once daily 4. The FDA label indicates this is the standard starting dose, with potential titration to 300 mg daily after one week if tolerated. However, in POTS patients, a more cautious approach is warranted.

• Initial dose: 150 mg XL once daily for 2-4 weeks
• Titration: If tolerated and additional benefit needed, increase to 300 mg XL once daily
• Maximum: Do not exceed 450 mg/day total (seizure risk increases above this threshold) 4

Evidence for Bupropion in POTS:

While bupropion is not mentioned in the Canadian Cardiovascular Society POTS guidelines [5-5], there is emerging evidence for its use. A retrospective study showed bupropion reduced syncope episodes in POTS patients, though it didn't significantly improve orthostatic vital signs 6. As a norepinephrine-dopamine reuptake inhibitor, bupropion theoretically could help with the autonomic dysfunction in POTS, particularly in syncope-predominant presentations 6.

POTS-Specific Considerations

Contraindications in POTS:

Bupropion is contraindicated in patients with seizure disorders or conditions that lower seizure threshold 4. This is particularly relevant if your POTS patient has:

• History of seizures
• Brain metastases or structural brain lesions
• Severe head trauma history
• Concurrent use of medications that lower seizure threshold

Monitoring Requirements:

1. Weeks 1-2 after starting bupropion: Weekly assessment for neuropsychiatric symptoms (anxiety, agitation, depression worsening, suicidal ideation) 4
2. Orthostatic vital signs: Check supine and standing heart rate/blood pressure at baseline and 2-4 weeks after each dose change
3. POTS symptom tracking: Monitor for changes in orthostatic intolerance, syncope frequency, fatigue, and other POTS symptoms

Integration with Standard POTS Management:

Continue evidence-based POTS treatments during this transition 5:

• Fluid intake: Minimum 3 L daily
• Salt supplementation: 10 g daily
• Compression garments: 20-30 mmHg waist-high stockings
• Exercise training: Semi-recumbent position initially (rowing, recumbent cycling)
• Consider propranolol: 10-20 mg four times daily if tachycardia remains problematic (strong recommendation, moderate-quality evidence) 5

Why This Approach Prioritizes Morbidity and Quality of Life

Abrupt sertraline discontinuation or inadequate tapering risks severe withdrawal symptoms that can mimic or worsen POTS symptoms (dizziness, tachycardia, anxiety), potentially leading to unnecessary medication resumption or emergency department visits. The gradual taper minimizes this risk while allowing assessment of whether sertraline was contributing to POTS symptoms.

Bupropion offers potential benefits for mood and possibly syncope reduction 6 without the sexual dysfunction and weight gain common with SSRIs, improving quality of life. However, the careful initiation after complete sertraline washout avoids drug-drug interactions and allows clear attribution of any symptom changes.